Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data

by Shedden, Kerby, Chen, Wei, Kuick, Rork, Ghosh, Debashis, Macdonald, James, Cho, Kathleen R, Giordano, Thomas J, Gruber, Stephen B, Fearon, Eric R, Taylor, Jeremy MG, Hanash, Samir
Published 2005

NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas

by Virani, Shama, Bellile, Emily, Bradford, Carol R., Carey, Thomas E., Chepeha, Douglas B., Colacino, Justin A., Helman, Joseph I., McHugh, Jonathan B., Peterson, Lisa A., Sartor, Maureen A., Taylor, Jeremy MG, Walline, Heather M., Wolf, Greg T., Rozek, Laura S.
Published 2015

Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas

by Colacino, Justin A., Arthur, Anna E., Dolinoy, Dana C., Sartor, Maureen A., Duffy, Sonia A., Chepeha, Douglas B., Bradford, Carol R., Walline, Heather M., McHugh, Jonathan B., D'Silva, Nisha, Carey, Thomas E., Wolf, Gregory T., Taylor, Jeremy M.G., Peterson, Karen E., Rozek, Laura S.
Published 2012

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

by McShane, Lisa M, Cavenagh, Margaret M, Lively, Tracy G, Eberhard, David A, Bigbee, William L, Williams, P Mickey, Mesirov, Jill P, Polley, Mei-Yin C, Kim, Kelly Y, Tricoli, James V, Taylor, Jeremy MG, Shuman, Deborah J, Simon, Richard M, Doroshow, James H, Conley, Barbara A
Published 2013